Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc. sells five SFDA approved medicines in China. Some 56 percent of its revenues are generated by Xin Aoxing Oleanolic Acid Capsules, the only SFDA-approved, OTC treatment for hepatitis B. Biostar is also building a raw material processing center. It began growing its own crops last year, and once the operation is producing fully, the company will be able to supply all of its own raw materials and sell to other TCM manufacturers.